juvenile idiopathic arthritis (JIA). Juvenile arthritis
Conditions
Interventions
Intervention 1: Intervention group: included patients will receive standard treatment of JIA and ginger pellets (containing hydro-alcoholic ginger extract equivalent to 250 mg of ginger rhizome powder
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 16 Years
Inclusion criteria
Inclusion criteria: Children (aged 6-16 years) referred to rheumatology clinic of Akbar hospital, who have been diagnosed with JIA according to the ACR Guideline. Obtaining informed consent of the patient / patient's parents
Exclusion criteria
Exclusion criteria: A child with a history of underlying disease, including cardiac, renal, hepatic, biliary, gastrointestinal, or rheumatic disorders (other than JIA), at the time of enrollment Use of anticoagulants (such as warfarin) or antiplatelet agents Diabetic patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease severity will be assessed at baseline, end of the first month, and end of the third month of treatment using the ACR-Pedi30 Score. The core criteria for ACR Pedi 30 score are: 1) physician global assessment of disease activity (PhGA); 2) parent/patient global assessment of overall well-being; 3) functional ability; 4) number of joints with active arthritis; 5) number of joints with limited range of motion; and 6) ESR. Timepoint: At baseline, end of the first month, and end of the third month of treatment. Method of measurement: 1) physician global assessment of disease activity (PhGA); 2) parent/patient global assessment of overall well-being; 3) functional ability; 4) number of joints with active arthritis; 5) number of joints with limited range of motion; and 6) ESR. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZinat Heidari
Mashhad University of Medical Sciences
Outcome results
None listed